These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 27542969)

  • 21. Comparison of immunohistochemistry with PCR for assessment of ER, PR, and Ki-67 and prediction of pathological complete response in breast cancer.
    Sinn HP; Schneeweiss A; Keller M; Schlombs K; Laible M; Seitz J; Lakis S; Veltrup E; Altevogt P; Eidt S; Wirtz RM; Marmé F
    BMC Cancer; 2017 Feb; 17(1):124. PubMed ID: 28193205
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ovariectomy in young prepubertal dairy heifers causes complete suppression of mammary progesterone receptors.
    Velayudhan BT; Huderson BP; Ellis SE; Parsons CL; Hovey RC; Rowson AR; Akers RM
    Domest Anim Endocrinol; 2015 Apr; 51():8-18. PubMed ID: 25460067
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of ERα-397 PvuII C/T, ERα-351 XbaI A/G and PGR PROGINS polymorphisms in Brazilian breast cancer-unaffected women.
    Giacomazzi J; Aguiar E; Palmero EI; Schmidt AV; Skonieski G; Filho DD; Bock H; Saraiva-Pereira ML; Ewald IP; Schuler-Faccini L; Camey SA; Caleffi M; Giugliani R; Ashton-Prolla P
    Braz J Med Biol Res; 2012 Oct; 45(10):891-7. PubMed ID: 22584640
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An international reproducibility study validating quantitative determination of ERBB2, ESR1, PGR, and MKI67 mRNA in breast cancer using MammaTyper®.
    Varga Z; Lebeau A; Bu H; Hartmann A; Penault-Llorca F; Guerini-Rocco E; Schraml P; Symmans F; Stoehr R; Teng X; Turzynski A; von Wasielewski R; Gürtler C; Laible M; Schlombs K; Joensuu H; Keller T; Sinn P; Sahin U; Bartlett J; Viale G
    Breast Cancer Res; 2017 May; 19(1):55. PubMed ID: 28490348
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Progesterone Receptor Gene Variants in Metastatic Estrogen Receptor Positive Breast Cancer.
    Fowler AM; Salem K; DeGrave M; Ong IM; Rassman S; Powers GL; Kumar M; Michel CJ; Mahajan AM
    Horm Cancer; 2020 Apr; 11(2):63-75. PubMed ID: 31942683
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reliable PCR quantitation of estrogen, progesterone and ERBB2 receptor mRNA from formalin-fixed, paraffin-embedded tissue is independent of prior macro-dissection.
    Tramm T; Hennig G; Kyndi M; Alsner J; Sørensen FB; Myhre S; Sørlie T; Overgaard J
    Virchows Arch; 2013 Dec; 463(6):775-86. PubMed ID: 24100522
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estrogen receptor 1 and progesterone receptor are distinct biomarkers and prognostic factors in estrogen receptor-positive breast cancer: Evidence from a bioinformatic analysis.
    Wu JR; Zhao Y; Zhou XP; Qin X
    Biomed Pharmacother; 2020 Jan; 121():109647. PubMed ID: 31733575
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The validation of estrogen receptor 1 mRNA expression as a predictor of outcome in patients with metastatic non-small cell lung cancer.
    Atmaca A; Al-Batran SE; Wirtz RM; Werner D; Zirlik S; Wiest G; Eschbach C; Claas S; Hartmann A; Ficker JH; Jäger E; Brueckl WM
    Int J Cancer; 2014 May; 134(10):2314-21. PubMed ID: 24174373
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Progesterone Receptor (PGR) Gene Variants Associated with Breast Cancer and Associated Features: a Case-Control Study.
    Ghali RM; Al-Mutawa MA; Ebrahim BH; Jrah HH; Zaied S; Bhiri H; Hmila F; Mahjoub T; Almawi WY
    Pathol Oncol Res; 2020 Jan; 26(1):141-147. PubMed ID: 29302853
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNAs link estrogen receptor alpha status and Dicer levels in breast cancer.
    Cochrane DR; Cittelly DM; Howe EN; Spoelstra NS; McKinsey EL; LaPara K; Elias A; Yee D; Richer JK
    Horm Cancer; 2010 Dec; 1(6):306-19. PubMed ID: 21761362
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationships of physical and breast cancer phenotypes with three single-nucleotide polymorphisms (rs2046210, rs3757318, and rs3803662) associated with breast cancer risk in Japanese women.
    Kawada K; Taira N; Mizoo T; Suzuki Y; Kajiwara Y; Hatono M; Tsukioki T; Kochi M; Abe Y; Nishiyama K; Iwamoto T; Ikeda H; Shien T; Doihara H; Ishihara S; Kawai H; Kawasaki K; Ishibe Y; Ogasawara Y; Toyooka S
    Breast Cancer; 2021 Mar; 28(2):478-487. PubMed ID: 33185851
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diverse associations between ESR1 polymorphism and breast cancer development and progression.
    Ding SL; Yu JC; Chen ST; Hsu GC; Hsu HM; Ho JY; Lin YH; Chang CC; Fann CS; Cheng CW; Wu PE; Shen CY
    Clin Cancer Res; 2010 Jul; 16(13):3473-84. PubMed ID: 20570923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ESR1 and ESR2 polymorphisms in the BIG 1-98 trial comparing adjuvant letrozole versus tamoxifen or their sequence for early breast cancer.
    Leyland-Jones B; Gray KP; Abramovitz M; Bouzyk M; Young B; Long B; Kammler R; Dell'Orto P; Biasi MO; Thürlimann B; Harvey V; Neven P; Arnould L; Maibach R; Price KN; Coates AS; Goldhirsch A; Gelber RD; Pagani O; Viale G; Rae JM; Regan MM;
    Breast Cancer Res Treat; 2015 Dec; 154(3):543-55. PubMed ID: 26590813
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of estrogen and progesterone receptor gene polymorphisms and their respective hormones in uterine leiomyomas.
    Veronica M; Ali A; Venkateshwari A; Mamata D; Nallari P
    Tumour Biol; 2016 Jun; 37(6):8067-74. PubMed ID: 26715264
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative determination of estrogen receptor, progesterone receptor, and HER2 mRNA in formalin-fixed paraffin-embedded tissue--a new option for predictive biomarker assessment in breast cancer.
    Müller BM; Kronenwett R; Hennig G; Euting H; Weber K; Bohmann K; Weichert W; Altmann G; Roth C; Winzer KJ; Kristiansen G; Petry C; Dietel M; Denkert C
    Diagn Mol Pathol; 2011 Mar; 20(1):1-10. PubMed ID: 21326033
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estrogen and progesterone receptor gene polymorphisms and sporadic breast cancer risk: a Spanish case-control study.
    Fernández LP; Milne RL; Barroso E; Cuadros M; Arias JI; Ruibal A; Benítez J; Ribas G
    Int J Cancer; 2006 Jul; 119(2):467-71. PubMed ID: 16477637
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Giredestrant reverses progesterone hypersensitivity driven by estrogen receptor mutations in breast cancer.
    Liang J; Ingalla ER; Yao X; Wang BE; Tai L; Giltnane J; Liang Y; Daemen A; Moore HM; Aimi J; Chang CW; Gates MR; Eng-Wong J; Tam L; Bacarro N; Roose-Girma M; Bellet M; Hafner M; Metcalfe C
    Sci Transl Med; 2022 Sep; 14(663):eabo5959. PubMed ID: 36130016
    [No Abstract]   [Full Text] [Related]  

  • 38. A candidate CpG SNP approach identifies a breast cancer associated ESR1-SNP.
    Harlid S; Ivarsson MI; Butt S; Hussain S; Grzybowska E; Eyfjörd JE; Lenner P; Försti A; Hemminki K; Manjer J; Dillner J; Carlson J
    Int J Cancer; 2011 Oct; 129(7):1689-98. PubMed ID: 21105050
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Common germline polymorphisms in COMT, CYP19A1, ESR1, PGR, SULT1E1 and STS and survival after a diagnosis of breast cancer.
    Udler MS; Azzato EM; Healey CS; Ahmed S; Pooley KA; Greenberg D; Shah M; Teschendorff AE; Caldas C; Dunning AM; Ostrander EA; Caporaso NE; Easton D; Pharoah PD
    Int J Cancer; 2009 Dec; 125(11):2687-96. PubMed ID: 19551860
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The variant T allele of PvuII in ESR1 gene is a prognostic marker in early breast cancer survival.
    Houtsma D; de Groot S; Baak-Pablo R; Kranenbarg EM; Seynaeve CM; van de Velde CJH; Böhringer S; Kroep JR; Guchelaar H-; Gelderblom H
    Sci Rep; 2021 Feb; 11(1):3249. PubMed ID: 33547330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.